Saturday, May 16, 2009

Electroboy versus Bristol Myers Squibb

Andy Behrman, author of Electroboy, made $400,000 pitching Abilify for BMS. Now he says he was lying, according to the Wall Street Journal. Read more here.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)